Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, taking Mounjaro two days late is generally within the window the medicine allows. The Mounjaro Patient Information Leaflet states that a missed dose can be taken up to four days after your scheduled injection day — so two days late still falls inside that range. That said, the right call for your specific situation is always one your prescriber should confirm. Mounjaro (tirzepatide) is a prescription-only medicine, and any questions about timing are best raised with whoever oversees your treatment. The NHS tirzepatide information page outlines general missed-dose guidance, and your Patient Information Leaflet has the exact detail for the formulation you're using.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The short answer is yes. The Mounjaro Patient Information Leaflet is clear that if you miss a scheduled injection, you can still take it up to four days (96 hours) later. Two days late lands well inside that window, so you have not missed the dose in any clinical sense, you've simply shifted the timing slightly.
Once you've injected, keep your next scheduled day exactly as it was before. You don't need to recalculate your whole schedule around the late injection; just resume from your usual weekly day. So if Friday is normally your day and you inject on Sunday, next Friday stays as planned.
This flexibility is built into the design of the medicine. Tirzepatide has a long half-life (it stays active in your body for around five days after each injection) which is why a short delay rarely disrupts the treatment meaningfully. It is still worth trying to stay consistent, because predictable timing helps your body adjust and keeps any gastrointestinal side effects manageable. But life happens. A work trip, a bank holiday, payday chaos that pushes your pharmacy order back a couple of days: these don't require a call to the clinic as long as you're still within four days. If you find yourself regularly pushing two or three days late, that's worth mentioning to your prescriber, and you can find out whether taking Mounjaro three days late changes the guidance if that situation comes up. Switching your injection day to something that fits your routine better is often all it takes.
Count from your scheduled injection day, not from when you last injected. If your usual day is Monday and you're injecting on Wednesday, that's two days late. If it's Thursday, that's three days. The four-day cutoff is firm: understanding exactly how many days late is acceptable matters because crossing that line changes what you should do.
At four days or fewer: inject as soon as you remember, then continue to your next scheduled day as normal. At five or more days: skip it. Taking a late dose after that window would compress two injections too closely, which raises the chance of side effects without adding meaningful benefit. The next scheduled dose is the right one to wait for. If you're genuinely unsure of the count, err on the side of skipping rather than doubling the amount of medicine in a short period.
The full guide on how late you can take Mounjaro covers the four-day rule in more detail, including what happens at each point in the window.
A single two-day delay is unlikely to change your tolerance at that dose level, provided you are established on Mounjaro and not in the early weeks of treatment. The gradual titration schedule exists to let your digestive system adapt (the starter dose is the body's settling-in period, not the therapeutic level) and a brief timing shift doesn't reset that process.
Where timing can matter is during dose increases. If you've recently moved up to a new strength and take that dose slightly later than intended, the usual advice still applies: take it within the four-day window, don't take an extra dose, and contact your prescriber if you have any concerns. Side effects like nausea, bloating or fatigue are most common in the first week or two after a dose change, so your prescriber is the best person to advise if a late injection coincides with a transition period.
For a broader picture of how Mounjaro's weekly structure works, the Mounjaro treatment overview covers the dosing schedule in context. And if you'd like to explore what treatment through a regulated online service looks like, our treatment page walks through the clinical process from consultation to delivery.
For a straightforward two-day delay on a stable dose, the leaflet guidance is enough. Contact your prescriber if: you are in the first four weeks of treatment and unsure whether the delay affects your titration plan; you've had a late dose several weeks in a row; you're experiencing side effects you weren't expecting; or you're also taking other medicines that could interact, particularly oral contraceptives (the NHS guidance for women taking the combined pill alongside Mounjaro recommends adding a barrier method for the first four weeks of treatment and after each dose increase, because the medicine slows gastric emptying in a way that can affect pill absorption).
A quick message to your prescribing service is always reasonable if something feels off. If you're being treated through a service that makes that contact difficult, it's worth knowing that aftercare access (seven days a week) is part of how a well-run service should work. You can read about how nume approaches clinical oversight or browse the most common questions our prescribers receive if you're comparing options.
Thinking about whether Mounjaro could be right for you in the first place? The BMI requirements for Mounjaro page sets out who the medicine is licensed for under UK guidance, and what the process of getting it looks like privately.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.